XvideosDemon
Monarch of aura
- Joined
- Feb 14, 2026
- Posts
- 4,063
- Reputation
- 10,716
WhosThat’s what’s up I love when you listen to daddy
WhosThat’s what’s up I love when you listen to daddy
Dream fr we will look so cute
Go make smoothies niggaSussy![]()
Where do you work might go there and try in the futureWe slow rn
![]()
nice, I recently researched fgfr3 Inhibition and this is very interesting mirin iqcould LOXO-435 be the best option for fgfr3 inhibtion ?
Patented by LILLY, LOXO-435 is a highly selective FGFR3 inhibitor
If you are unsure of what fgfr3 does-
https://looksmax.gg/threads/fgfr3-inhibtion-epiphyseal-plates-and-bone-growth.19180/
LOXO-435 is confined to oncologic trials, no pediatric or skeletal growth studies have been initiated.
comparisons
Safety. Sides. Efficacy.
LOXO high very low high VORS high near to none mid ERDA low very high high INFI mid mid high
View attachment 38569
Until next time
Loxo-435
View attachment 38568
LOXO-435 is the most selective inhibitor studied to date. 361-fold selectivity over FGFR1 and 66-fold over FGFR2 .
This matters because pan-FGFR inhibitors (erdafitinib, infigratinib) hit FGFR1/2/4 and cause body wide toxicities, skin disorders, phosphatemia and more.
Unlike vosoritide and meclozine, which act indirectly via the CNP/cGMP pathway or analogous pathways, LOXO-435, as a direct small molecule inhibitor of the FGFR3 kinase, binds the receptor directly.
(Its direct)
Loxo is oral and taken twice a day (once may be adequate for plates). Around 100mg a day. Theoretically a 2 month onset
View attachment 38567View attachment 38570
Loxo imo, a very promising inhibitor
Highly effective
Highly selective
Direct
Cheap
But long onset
Studies
https://share.google/upuke5VGU4FyoD2bl
https://share.google/skUVinxfXwPurjQmt
https://aacrjournals.org/mct/articl...scovery-of-a-highly-potent-and?sharetype=link
Short thread ik
Yall think ive stepped up my content recently ?
Dexter
birthdefect
carbon
Synapse
Mandy
tmpll
XvideosDemon
9Dino
Fram3Let
6ft1Cheat
Tismo
determinism
Hyporoxin
brownkeephittin
biomaxx
Im boutta buuuuumppppcould LOXO-435 be the best option for fgfr3 inhibtion ?
Patented by LILLY, LOXO-435 is a highly selective FGFR3 inhibitor
If you are unsure of what fgfr3 does-
https://looksmax.gg/threads/fgfr3-inhibtion-epiphyseal-plates-and-bone-growth.19180/
LOXO-435 is confined to oncologic trials, no pediatric or skeletal growth studies have been initiated.
comparisons
Safety. Sides. Efficacy.
LOXO high very low high VORS high near to none mid ERDA low very high high INFI mid mid high
View attachment 38569
Until next time
Loxo-435
View attachment 38568
LOXO-435 is the most selective inhibitor studied to date. 361-fold selectivity over FGFR1 and 66-fold over FGFR2 .
This matters because pan-FGFR inhibitors (erdafitinib, infigratinib) hit FGFR1/2/4 and cause body wide toxicities, skin disorders, phosphatemia and more.
Unlike vosoritide and meclozine, which act indirectly via the CNP/cGMP pathway or analogous pathways, LOXO-435, as a direct small molecule inhibitor of the FGFR3 kinase, binds the receptor directly.
(Its direct)
Loxo is oral and taken twice a day (once may be adequate for plates). Around 100mg a day. Theoretically a 2 month onset
View attachment 38567View attachment 38570
Loxo imo, a very promising inhibitor
Highly effective
Highly selective
Direct
Cheap
But long onset
Studies
https://share.google/upuke5VGU4FyoD2bl
https://share.google/skUVinxfXwPurjQmt
https://aacrjournals.org/mct/articl...scovery-of-a-highly-potent-and?sharetype=link
Short thread ik
Yall think ive stepped up my content recently ?
Dexter
birthdefect
carbon
Synapse
Mandy
tmpll
XvideosDemon
9Dino
Fram3Let
6ft1Cheat
Tismo
determinism
Hyporoxin
brownkeephittin
biomaxx
Sorry js realised is replied w jfl, wasnt on purposenice, I recently researched fgfr3 Inhibition and this is very interesting mirin iq
Why can't all my threads get there own little section,could LOXO-435 be the best option for fgfr3 inhibtion ?
Patented by LILLY, LOXO-435 is a highly selective FGFR3 inhibitor
If you are unsure of what fgfr3 does-
https://looksmax.gg/threads/fgfr3-inhibtion-epiphyseal-plates-and-bone-growth.19180/
LOXO-435 is confined to oncologic trials, no pediatric or skeletal growth studies have been initiated.
comparisons
Safety. Sides. Efficacy.
LOXO high very low high VORS high near to none mid ERDA low very high high INFI mid mid high
View attachment 38569
Until next time
Loxo-435
View attachment 38568
LOXO-435 is the most selective inhibitor studied to date. 361-fold selectivity over FGFR1 and 66-fold over FGFR2 .
This matters because pan-FGFR inhibitors (erdafitinib, infigratinib) hit FGFR1/2/4 and cause body wide toxicities, skin disorders, phosphatemia and more.
Unlike vosoritide and meclozine, which act indirectly via the CNP/cGMP pathway or analogous pathways, LOXO-435, as a direct small molecule inhibitor of the FGFR3 kinase, binds the receptor directly.
(Its direct)
Loxo is oral and taken twice a day (once may be adequate for plates). Around 100mg a day. Theoretically a 2 month onset
View attachment 38567View attachment 38570
Loxo imo, a very promising inhibitor
Highly effective
Highly selective
Direct
Cheap
But long onset
Studies
https://share.google/upuke5VGU4FyoD2bl
https://share.google/skUVinxfXwPurjQmt
https://aacrjournals.org/mct/articl...scovery-of-a-highly-potent-and?sharetype=link
Short thread ik
Yall think ive stepped up my content recently ?
Dexter
birthdefect
carbon
Synapse
Mandy
tmpll
XvideosDemon
9Dino
Fram3Let
6ft1Cheat
Tismo
determinism
Hyporoxin
brownkeephittin
biomaxx


